Skip to main content
. 2011 Jul 5;17(11-12):1157–1167. doi: 10.2119/molmed.2011.00144

Figure 1.

Figure 1

Circulating levels of calprotectin and sRAGE of LN, obese NG and obese T2D volunteers as well as the effect of weight loss in obese patients achieved by RYGB. Bars represent the mean ± SEM of calprotectin and sRAGE plasma concentrations under basal conditions (LN: n = 16; NG: n = 20; T2D: n = 17) (A, B) and 13 months after RYGB (n = 26) (C, D). Differences between groups were analyzed by one-way ANOVA followed by Tukey tests or by two-tailed paired Student t tests. **P < 0.01 versus LN and versus presurgery values.